<DOC>
	<DOCNO>NCT00634543</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness safety tramadol hydrochloride ( HCl ) 37.5 miligram ( mg ) /acetaminophen 325 mg compare gabapentin participant diabetic neuropathic ( nerve disorder cause diabetes mellitus ) pain .</brief_summary>
	<brief_title>A Study Compare Safety Efficacy Tramadol Hydrochloride/Acetaminophen With Gabapentin Participants With Diabetic Neuropathy</brief_title>
	<detailed_description>This open-label ( medical research study participant researcher tell treatment participant receive , `` unblinded '' ) , multi-center randomized ( study drug assign chance ) study compare effectiveness safety tramadol HCl 37.5 mg/acetaminophen 325 mg gabapentin participant diabetic neuropathy . The study consist 4 period : Screening period ( Day -14 ) , Randomization period ( Day 1 ) , Dosage adjustment period ( Day 15 ) Maintenance period ( Day 43 ) . The participant randomly assign 1 2 treatment group : tramadol HCl 37.5 mg/acetaminophen 325 mg gabapentin . Tramadol Hcl/acetaminophen group receive 1 tablet 3 day , 1 tablet twice daily 4 day follow 1 tablet thrice daily next 7 day . If pain relief , dosage increase 8 tablet per day Day 15 28 , increase dosage maintain Day 29 42 . Gabapentin group receive 300 mg Day 1 , 300 mg twice daily Day 2 , 300 mg thrice daily Day 3 7 . Then Day 8 14 , participant receive 300 mg morning , 300 mg midday 600 mg evening . If pain relief , gabapentin increase 3600 mg per day Day 15 28 , increase dosage maintain Day 29 42 . Primarily , efficacy evaluate pain intensity use numeric rating scale ( NRS ) . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Participants painful symmetric neuropathy ( disturbance function brain spinal cord may affect nerve muscle body ) low limbs applicable following condition : decrease sensation leg monofilament , none decrease ankle reflex decrease vibratory sensation pain symptom numbness ( loss sensation ) , tingle , paresthesia ( skin sensation , burning , prickle , itch , tingle , apparent physical cause ) , burn , shoot pain , stab lancinating ( characterized sensation cutting , pierce , stab ) pain Participants painful diabetic neuropathy low limb 3 month randomization Participants diagnose Type diabetes stable blood sugar level control oral medication , insulin diet therapy 3 month randomization Participants glycated hemoglobin ( HbA1c ) less equal 10 percent Participants pain intensity score great equal 4 numeric rating scale ( NRS ) last 48 hour Participants previously experience failure tramadol treatment discontinue tramadol administration due adverse event Participants receive prohibited medication randomization ( e.g. , capsaicin , use systemic steroid , steroid local anesthetic injection , tramadol HCl tramadol combination , gabapentin , opioid analgesic , antidepressant , anticonvulsant , alphalipoic acid , acupuncture , COX2 selective inhibitor , longacting NSAIDs , opioid analgesic , sedativehypnotics , muscle relaxant , anxiolytic , antipsychotic , TENS , shortacting nonopioid analgesic ) Participants neuropathic pain cause reason ( e.g. , alcohol abuse , connective tissue disease , toxic exposure , infection , neoplasm , ischemia ) Participants suffer painful diabetic neuropathy 10 year Participants physical damage disease may cause abnormal absorption , excessive accumulation , metabolism excretion disorder study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Diabetic neuropathy</keyword>
	<keyword>Ultracet</keyword>
	<keyword>Tramadol hydrochloride</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Gabapentin</keyword>
</DOC>